10 research outputs found
Fraktionierte stereotaktische Strahlentherapie bei Nebennierenmetastasen: Beitrag zur lokalen Tumorkontrolle mit geringer Toxizität
Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
Renal Origin and Size are Independent Predictors of Survival After Surgery for Adrenal Metastasis
Oligometastatic non-small-cell lung cancer: local treatment options for pulmonary and adrenal metastases
The efficacy of conventional external beam, three-dimensional conformal, intensity-modulated, particle beam radiation, and brachytherapy for localized prostate cancer
Stereotactic body radiotherapy
Stereotactic body radiation therapy (SBRT) consists of the delivery of precise, conformal, hypofractionated, and ablative therapy in a single or a small number of fractions to extracranial regions. Over the last decade, it is rapidly being integrated into mainstream radiation oncology practices. The indications for SBRT continue to grow, as does the technology associated with its delivery. This chapter presents a detailed overview of clinically relevant topics including patient selection and outcomes, and the technological aspects of planning and delivery of SBRT. The tumor streams covered in this chapter are lung, liver, spine, pancreas, renal cell carcinoma, adrenal, prostate, and head and neck. The chapter concludes by highlighting two novel areas, cardiac arrhythmias and pediatric oncology, in which the use of SBRT is emerging